A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory bowel disease from healthy control individuals.

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Crohn’s disease can cause digestive issues However since it is an inflammatory disease the symptoms can go beyond the gut ...

There is a significant burden of undiagnosed SpA in IBD, with many patients reporting musculoskeletal symptoms.

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

In a US study, researchers found that 35% of adults with IBD screened positive for spondyloarthritis, despite having no known SpA diagnosis.

IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...

Body Changes Up to Eight Years Before Inflammatory Bowel Disease Diagnosis Nov. 7, 2023 — Researchers have shown that changes can be detected in blood tests up to eight years before a diagnosis ...